Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published online July 17 in JAMA Dermatology.

Katelyn J. Rypka, from the University of Minnesota in Minneapolis, and colleagues examined differences in the lifetime prevalence of skin cancer among U.S. adult females and males by sexual orientation in a cross-sectional study using data from the Behavioral Risk Factor Surveillance System from Jan. 1, 2014, to Dec. 31, 2021. Of the 1,512,400 participants studied, 53.2, 2.6, 42.2 and 2.0 percent were heterosexual females, SM females, heterosexual males, and SM males, respectively.

The researchers found that the lifetime prevalence of skin cancer was higher for SM males versus heterosexual males overall (7.4 versus 6.8 percent; adjusted odds ratio [aOR], 1.16), especially among Hispanic males (4.0 versus 1.6 percent; aOR, 3.81) and non-Hispanic Black males (1.0 versus 0.5 percent; aOR, 2.18). Compared with heterosexual females, lifetime prevalence rates were lower among SM females for non-Hispanic Whites (7.8 versus 8.5 percent; aOR, 0.86), while rates were higher among Hispanic SM females (2.1 versus 1.8 percent; aOR, 2.46) and non-Hispanic Black SM females (1.8 versus 0.5 percent; aOR, 2.33).

"Future research and public health interventions should consider race and ethnicity and individual sexual identity when addressing skin cancer and related risk behaviors, with a particular emphasis on Black and Hispanic SM females and males and White gay males," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-20 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords